The Value of Attending Our Programs

The Value of Attending Our Programs

Q1 Productions offers exceptional programs in which we develop and deliver executive education to highly regulated industries. Whether it is a conference, forum or webinar, there is great value in attending one of our 50+ programs. Many companies may wonder if it is a...
Session Preview: Data Analytics for Portfolio Strategy

Session Preview: Data Analytics for Portfolio Strategy

Matthew Kokkonen of CSL Behring is one of many distinguished speakers featured at Q1’s 2nd Annual Pharmaceutical Portfolio Strategy & Management Conference taking place this May. He provided Q1 the opportunity to preview his upcoming masterclass, “Leverage of Data...
Patient Reported Outcomes’ Influence on Pre-Launch Activities

Patient Reported Outcomes’ Influence on Pre-Launch Activities

Q1’s 4th Annual Pharma & Biotech Medical Affairs Pre-Launch Strategies Conference features an array of payer, legal and industry perspectives, including Ann Leon of CSL Behring. Learn about her experience and upcoming session below!   Can you please give a...

ICH Q12 EU Compatibility

The International Council for Harmonization (ICH) works to make global trade in the pharmaceutical industry easier. According to a recent article, the ICH “issued in December of 2017 a draft guidance aimed at more uniformity in rules on the quality of medicines...

Combination Products Approval Operations with Art Faulkner

Combination Products Approval Operations with Art Faulkner   Art Faulkner, VP, Regulatory CMC at TG Therapeutics, is one of many distinguished presenters at this year’s 4th Annual Regulatory Affairs CMC: Chemistry, Manufacturing, and Controls Conference. His...